share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  06/14 04:16
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Recursion藥品公司官員Secora Michael計劃於2024年06月13日出售15,000股A類股份，市場總價值爲$139,798.24。出售的股票是通過限制性股票歸屬和於2023年05月15日和06月13日進行的股票期權行權而獲得的。該證券直接從發行人獲得作爲補償和現金支付的一部分。在過去三個月中，已經完成一系列資產的銷售，總銷售收入爲$642,823。
Recursion藥品公司官員Secora Michael計劃於2024年06月13日出售15,000股A類股份，市場總價值爲$139,798.24。出售的股票是通過限制性股票歸屬和於2023年05月15日和06月13日進行的股票期權行權而獲得的。該證券直接從發行人獲得作爲補償和現金支付的一部分。在過去三個月中，已經完成一系列資產的銷售，總銷售收入爲$642,823。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。